Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Immunohistochemical detection of chemokine receptor 4 expression in chronic osteomyelitis confirms specific uptake in 68Ga-Pentixafor-PET/CT.

Bouter Y, Meller B, Sahlmann CO, Wolf BJ, Langer L, Bankstahl JP, Wester HJ, Kropf S, Meller J, Bouter C.

Nuklearmedizin. 2018 Sep;57(5):198-203. doi: 10.3413/Nukmed-0971-18-04. Epub 2018 Sep 28.

PMID:
30267402
2.

Synergistic Effect on Neurodegeneration by N-Truncated Aβ4-42 and Pyroglutamate Aβ3-42 in a Mouse Model of Alzheimer's Disease.

Lopez-Noguerola JS, Giessen NME, Ueberück M, Meißner JN, Pelgrim CE, Adams J, Wirths O, Bouter Y, Bayer TA.

Front Aging Neurosci. 2018 Mar 8;10:64. doi: 10.3389/fnagi.2018.00064. eCollection 2018.

3.

Synaptic Alterations in Mouse Models for Alzheimer Disease-A Special Focus on N-Truncated Abeta 4-42.

Dietrich K, Bouter Y, Müller M, Bayer TA.

Molecules. 2018 Mar 21;23(4). pii: E718. doi: 10.3390/molecules23040718. Review.

4.

Expression of the Alzheimer's Disease Mutations AβPP695sw and PSEN1M146I in Double-Transgenic Göttingen Minipigs.

Jakobsen JE, Johansen MG, Schmidt M, Liu Y, Li R, Callesen H, Melnikova M, Habekost M, Matrone C, Bouter Y, Bayer TA, Nielsen AL, Duthie M, Fraser PE, Holm IE, Jørgensen AL.

J Alzheimers Dis. 2016 Jul 14;53(4):1617-30. doi: 10.3233/JAD-160408.

PMID:
27540966
5.

Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.

Weissmann R, Hüttenrauch M, Kacprowski T, Bouter Y, Pradier L, Bayer TA, Kuss AW, Wirths O.

J Alzheimers Dis. 2016;50(2):397-409. doi: 10.3233/JAD-150745.

PMID:
26639971
6.

Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X.

Antonios G, Borgers H, Richard BC, Brauß A, Meißner J, Weggen S, Pena V, Pillot T, Davies SL, Bakrania P, Matthews D, Brownlees J, Bouter Y, Bayer TA.

Sci Rep. 2015 Dec 2;5:17338. doi: 10.1038/srep17338.

7.

Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.

Storck SE, Meister S, Nahrath J, Meißner JN, Schubert N, Di Spiezio A, Baches S, Vandenbroucke RE, Bouter Y, Prikulis I, Korth C, Weggen S, Heimann A, Schwaninger M, Bayer TA, Pietrzik CU.

J Clin Invest. 2016 Jan;126(1):123-36. doi: 10.1172/JCI81108. Epub 2015 Nov 30.

8.

Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N‑truncated Abeta in sporadic Alzheimer disease cases and mouse models.

Bouter Y, Lopez Noguerola JS, Tucholla P, Crespi GA, Parker MW, Wiltfang J, Miles LA, Bayer TA.

Acta Neuropathol. 2015 Nov;130(5):713-29.

PMID:
26467270
9.

Neuron Loss and Behavioral Deficits in the TBA42 Mouse Model Expressing N-Truncated Pyroglutamate Amyloid-β3-42.

Meißner JN, Bouter Y, Bayer TA.

J Alzheimers Dis. 2015;45(2):471-82. doi: 10.3233/JAD-142868.

PMID:
25547635
10.

Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing.

Bouter Y, Kacprowski T, Weissmann R, Dietrich K, Borgers H, Brauß A, Sperling C, Wirths O, Albrecht M, Jensen LR, Kuss AW, Bayer TA.

Front Aging Neurosci. 2014 Apr 16;6:75. doi: 10.3389/fnagi.2014.00075. eCollection 2014.

11.

Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.

Guzmán EA, Bouter Y, Richard BC, Lannfelt L, Ingelsson M, Paetau A, Verkkoniemi-Ahola A, Wirths O, Bayer TA.

Mol Neurodegener. 2014 Apr 2;9:13. doi: 10.1186/1750-1326-9-13.

12.

N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody.

Antonios G, Saiepour N, Bouter Y, Richard BC, Paetau A, Verkkoniemi-Ahola A, Lannfelt L, Ingelsson M, Kovacs GG, Pillot T, Wirths O, Bayer TA.

Acta Neuropathol Commun. 2013 Sep 6;1:56. doi: 10.1186/2051-5960-1-56.

13.

N-truncated amyloid β (Aβ) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits.

Bouter Y, Dietrich K, Wittnam JL, Rezaei-Ghaleh N, Pillot T, Papot-Couturier S, Lefebvre T, Sprenger F, Wirths O, Zweckstetter M, Bayer TA.

Acta Neuropathol. 2013 Aug;126(2):189-205. doi: 10.1007/s00401-013-1129-2. Epub 2013 May 18.

Supplemental Content

Loading ...
Support Center